Stock Analiz

Olema Oncology, Inc. (OLMA) stock forecast and price target

Price $7.56 · data as of November 13, 2026

12-month price target

Average target$35.50
Upside / downside+369.6%
Analysts10
ConsensusStrong buy
Low $13.00Average $35.50High $59.00

Gold marker: average target · white marker: today’s price ($7.56)

Analyst ratings

Strong buy 2Buy 9Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-2.56−36.8%$0
Next fiscal year
ends December 31, 2027
$-2.90−13.3%$14M
Quarter after
ends December 31, 2026
$-0.70−41.0%$0

Consensus of the analysts covering Olema Oncology, updated daily. In the last 30 days 1 estimates were raised and 7 lowered.

Frequently asked questions

What is the Olema Oncology stock price target?

The average 12-month target from 10 analysts is $35.50, 369.6% above the current price of $7.56 Targets range from $13.00 to $59.00.

Is Olema Oncology a buy according to analysts?

The consensus rating is “Strong buy” (2 strong buy, 9 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Olema Oncology expected to earn?

Analysts expect EPS of $-2.56 for the fiscal year ending December 31, 2026 and $-2.90 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.